Quick answer
International Business Machines Corp (IBM) reported revenue of $67.53B and net income of $10.59B for the fiscal year ended 2025-12-31, up 7.6% from $62.75B the year before, per its 10-K filed with the SEC on 2026-02-24. Long-term debt stood at $54.84B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $67.53B | $10.59B | $54.84B |
| 2024 (FY ending 2024-12-31) | $62.75B | $6.02B | $49.88B |
| 2023 (FY ending 2023-12-31) | $61.86B | $7.50B | $50.12B |
| 2022 (FY ending 2022-12-31) | $60.53B | $1.64B | $46.19B |
| 2021 (FY ending 2021-12-31) | $57.35B | $5.74B | $44.92B |
| 2020 (FY ending 2020-12-31) | $55.18B | $5.59B | $54.22B |
| 2019 (FY ending 2019-12-31) | $57.71B | $9.43B | $54.10B |
| 2018 (FY ending 2018-12-31) | $79.59B | $8.73B | $42.66B |
| 2017 (FY ending 2017-12-31) | $79.14B | $5.75B | $45.05B |
| 2016 (FY ending 2016-12-31) | $79.92B | $11.87B | $40.89B |
Related
- HUM revenue, net income and debt history (Humana Inc)
- HUT revenue, net income and debt history (Hut 8 Corp.)
- HWM revenue, net income and debt history (Howmet Aerospace Inc.)
- IBRX revenue, net income and debt history (Immunitybio, Inc.)
- ICE revenue, net income and debt history (Intercontinental Exchange, Inc.)
- IDA revenue, net income and debt history (Idacorp Inc)
- IDCC revenue, net income and debt history (Interdigital, Inc.)
- IDXX revenue, net income and debt history (Idexx Laboratories Inc /De)
Last updated 2026-10-16. Data only, not financial or tax advice.